InterMune, Myriad battered in early action

Shares of InterMune Inc. and Myriad Genetics both hit the skids early Wednesday as the broader market retreated on continued concerns about the growing sovereign debt crisis in Europe.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.